Fundraising Fox
Evogene Ltd.
NASDAQ: EVGNRehovot, IL · Israel corporation · 3 known investors
Find your way into Evogene Ltd.
Sign up to see every warm intro you have to Evogene Ltd.
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Evogene Ltd. team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Evogene applies computational chemistry and generative AI to design small molecules for commercial product development in the pharmaceutical and agricultural chemical industries. Its ChemPass AI engine generates and optimizes molecules across multiple parameters to support drug discovery and ag-chemical product development.
Founders & leadership
Board
Investors · 3
How we know: press coverage · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: board seat on SEC Form D · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$3.4M disclosed across 1 of 2 rounds · 2024–2026
▶$3.4MraisedFeb 2026 · 1 investors · PharmaceuticalsRule 506(b)
- Nir NimrodiDirector
- Sarit FironDirector
- Dan FalkDirector
- Gabi TarcicExecutive Officer
- Leon Yehuda RecanatiDirector
- Ofer HavivExecutive Officer, Director
- Ilia ZhidkovExecutive Officer
- Adrian PercyDirector
- Yaron EldadExecutive Officer
- Offering amount
- $3.4M
- Amount sold
- $3.4M
- Sales commissions
- $236.9K
- Placement agents
- A.G.P./Alliance Global Partners
- First sale
- Feb 2026
- Incorporated
- Corporation, Israel
- Federal exemptions
- 06b
▶$12MofferedSep 2024 · 1 investors · OtherRule 506(b)
- Nir NimrodiDirector
- Sarit FironDirector
- Yaron EldadExecutive Officer
- Eyal RonenExecutive Officer
- Dan FalkDirector
- Sassi MasliahExecutive Officer
- Oded ShoseyovDirector
- Adrian PercyDirector
- Ofer HavivExecutive Officer
- Leon Y. RecanatiDirector
- Mark KapelExecutive Officer
- Offering amount
- $12M
- Sales commissions
- $385K
- Placement agents
- A.G.P./Alliance Global Partners
- First sale
- Aug 2024
- Incorporated
- Corporation, Israel
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Evogene Ltd. went on to found or lead other companies.
Frequently asked questions
- What does Evogene Ltd. do?
- Evogene applies computational chemistry and generative AI to design small molecules for commercial product development in the pharmaceutical and agricultural chemical industries. Its ChemPass AI engine generates and optimizes molecules across multiple parameters to support drug discovery and ag-chemical product development.
- Who are Evogene Ltd.'s investors?
- Evogene Ltd.'s investors include Alpha Capital, ARK Investment Management, Team8.
- How much funding has Evogene Ltd. raised?
- Evogene Ltd. has disclosed $3.4M raised across 1 of its 2 known rounds.
- Where is Evogene Ltd. headquartered?
- Evogene Ltd. is headquartered in Rehovot, IL.